Sign in or Register
  • Home
    • The story of Aurigene
    • The Aurigene approach
    • Our impact
    • Media center
    • Our publications
  • About Us
    • Our journey
    • Our purpose
    • Our Core Values
    • Our milestones
    • Management Team
    • Board of Directors
    • Scientific Advisors
  • Science
    • Science
      • Our research
      • Our platform technologies
      • Our publications
    • Pipeline
      • Proprietary Pipeline
      • Clinical Candidates from Partnered Programs
  • News and Events
    • Aurigene in the media
    • News
    • Events
  • Careers
    • Life at Aurigene
    • Working at Aurigene
    • Perks at Aurigene
    • Teamwork
    • Current Openings
    • A word from Aurigeneans
  • Contact Us
Aurigene
Home
  • Home
    • The story of Aurigene
    • The Aurigene approach
    • Our impact
    • Media center
    • Our publications
  • About Us
    • Our journey
    • Our purpose
    • Our Core Values
    • Our milestones
    • Management Team
    • Board of Directors
    • Scientific Advisors
  • Science
    • Science
      • Our research
      • Our platform technologies
      • Our publications
    • Pipeline
      • Proprietary Pipeline
      • Clinical Candidates from Partnered Programs
  • News and Events
    • Aurigene in the media
    • News
    • Events
  • Careers
    • Life at Aurigene
    • Working at Aurigene
    • Perks at Aurigene
    • Teamwork
    • Current Openings
    • A word from Aurigeneans
  • Contact Us
  1. Home
  2. Publication
  3. Page 6
April 28, 2023
by admin aurigene

Developing Selective Inhibitors Of Ptp1b Over TcCPTP.

April 28, 2023
by admin aurigene

Synthesis and Biological Evaluation of 3-(4-aminophenyl)-2-(1H-indol-3-yl)Propanamide derivatives as novel PTP1B Inhibitors

April 28, 2023
by admin aurigene

Preliminary safety evaluation of novel small molecule inhibitors of caspase-3

April 28, 2023
by admin aurigene

Demonstration of anti-tumor efficacy in multiple preclinical cancer models using a novel peptide inhibitor (Aurigene-012) of the PD-1 signaling pathway

April 28, 2023
by admin aurigene

Identification of PI3K isoform selective inhibitors for treatment of inflammatory indications

April 28, 2023
by admin aurigene

Inhibition of matriptase results in efficacy in preclinical models of osteoarthritis

April 28, 2023
by admin aurigene

Diphenylether derivative as selective inhibitor of protein tyrosine phosphatase 1B (PTP1B) over t-cell protein tyrosine phosphatase (TCPTP) identified through virtual screening

April 28, 2023
by admin aurigene

Design and synthesis of 2-substituted benzoxazoles as novel PTP1B inhibitors

April 28, 2023
by admin aurigene

Discovery of 7-azaindole based anaplastic lymphoma kinase (ALK) inhibitors: wild type and mutant (L1196M) active compounds with unique binding mode

April 28, 2023
by admin aurigene

Discovery of PyridylBis(oxy)benzamide Derivatives as Selective Matriptase Inhibitors

1... 45678... 17
Home
  • Pipeline
  • Publications
  • Science
  • News and Events
  • Careers
Careers
Contact Us
Linkedin X-twitter

Governance

Code of Business Conduct
and Ethics

  • Statement of Policy
  • Link to Raise Concerns

Annual Reports

  • Link to View Report

Safety, Health, Environment
and Sustainability

  • Policy Statement and Reports

Information Security
Management System

  • ISO/IEC 27001:2022 Certificate

Policies

CSR

  • Commitee
  • Statement of Policy
  • Guiding Principles
  • Activities

Remuneration Policy

  • Statement of Policy

© 2022 Aurigene Discovery Technologies

Privacy & GDPR policy

Cookie policy

Crafted by: Pink Lemonade Communications Pvt. Ltd.

© 2022 Aurigene Oncology

Privacy and GDPR Policy

Cookie Policy

Apply Now